Almasio P - Search Results

1

Soluble adhesion molecules correlate with liver inflammation and fibrosis in chronic hepatitis C treated with interferon-alpha.

Lo Iacono O, García-Monzón C, Almasio P, García-Buey L, Craxí A, Moreno-Otero R. Lo Iacono O, et al. Among authors: almasio p. Aliment Pharmacol Ther. 1998 Nov;12(11):1091-9. doi: 10.1046/j.1365-2036.1998.00412.x. Aliment Pharmacol Ther. 1998. PMID: 9845398

2

The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C.

Lo Iacono O, Venezia G, Petta S, Mineo C, De Lisi S, Di Marco V, Rodolico V, Amato M, Ferraro D, Giordano C, Almasio PL, Craxí A. Lo Iacono O, et al. Among authors: almasio pl. Aliment Pharmacol Ther. 2007 May 15;25(10):1181-91. doi: 10.1111/j.1365-2036.2007.03309.x. Aliment Pharmacol Ther. 2007. PMID: 17451564

3

Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon.

Almasio PL, Di Marco V, Bonura C, Fuschi P, Camma C, Lo Iacono O, Artini M, Natoli C, Di Stefano R, Levrero M, Craxi A. Almasio PL, et al. Dig Dis Sci. 1999 May;44(5):1013-9. doi: 10.1023/a:1026625001168. Dig Dis Sci. 1999. PMID: 10235612 Clinical Trial.

4

High-dose prolonged combination therapy in non-responders to interferon monotherapy for chronic hepatitis C.

Di Marco V, Vaccaro A, Ferraro D, Alaimo G, Rodolico V, Parisi P, Peralta S, Di Stefano R, Almasio PL, Craxì A. Di Marco V, et al. Among authors: almasio pl. Aliment Pharmacol Ther. 2001 Jul;15(7):953-8. doi: 10.1046/j.1365-2036.2001.01005.x. Aliment Pharmacol Ther. 2001. PMID: 11421869 Clinical Trial.

5

Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response.

Pagliaro L, Craxí A, Cammaá C, Tiné F, Di Marco V, Lo Iacono O, Almasio P. Pagliaro L, et al. Among authors: almasio p. Hepatology. 1994 Apr;19(4):820-8. Hepatology. 1994. PMID: 8138252 Clinical Trial.

6

Transfusion-associated chronic hepatitis C: alpha-n1 interferon for 6 vs. 12 months.

Craxì A, Di Marco V, Lo Iacono O, Almasio P, Bruno R, Cammà C, Volpes R, Pagliaro L. Craxì A, et al. Among authors: almasio p. J Hepatol. 1996 May;24(5):539-46. doi: 10.1016/s0168-8278(96)80138-3. J Hepatol. 1996. PMID: 8773908 Clinical Trial.

7

Long-term efficacy of alpha-interferon in beta-thalassemics with chronic hepatitis C.

Di Marco V, Lo Iacono O, Almasio P, Ciaccio C, Capra M, Rizzo M, Malizia R, Maggio A, Fabiano C, Barbaria F, Craxì A. Di Marco V, et al. Among authors: almasio p. Blood. 1997 Sep 15;90(6):2207-12. Blood. 1997. PMID: 9310471 Free article. Clinical Trial.

8

Long-term course of interferon-treated chronic hepatitis C.

Cammà C, Di Marco V, Lo Iacono O, Almasio P, Giunta M, Fuschi P, Vaccaro A, Fabiano C, Magrin S, Di Stefano R, Bonura C, Pagliaro L, Craxì A. Cammà C, et al. Among authors: almasio p. J Hepatol. 1998 Apr;28(4):531-7. doi: 10.1016/s0168-8278(98)80274-2. J Hepatol. 1998. PMID: 9566819 Clinical Trial.

9

Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey.

Stroffolini T, Colloredo G, Gaeta GB, Sonzogni A, Angeletti S, Marignani M, Pasquale G, Venezia G, Craxì A, Almasio P. Stroffolini T, et al. Among authors: almasio p. J Viral Hepat. 2004 May;11(3):257-62. doi: 10.1111/j.1365-2893.2004.00489.x. J Viral Hepat. 2004. PMID: 15117328

10

Hepatic hepatitis C virus RNA in chronic hepatitis C.

Craxì A, Di Marco V, Almasio PL. Craxì A, et al. Among authors: almasio pl. Ann Intern Med. 1996 Jan 1;124(1 Pt 1):72. doi: 10.7326/0003-4819-124-1_part_1-199601010-00016. Ann Intern Med. 1996. PMID: 7503483 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

200 results

Search Page

Filters